Jarvis Rodgers - Federal News Network

Jarvis Rodgers

FILE - A sign for the Food and Drug Administration is seen in Silver Spring, Md., on Thursday, Dec. 10, 2020. On Wednesday, March 30, 2022, federal health advisers narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig’s disease, a potential setback for patient groups who lobbied for the medication’s approval. A majority of advisers to the FDA voted 6-4 that a single study from Amylyx Pharmaceuticals failed to establish the drug's effectiveness in treating the deadly neurodegenerative disease known also as ALS, for amyotrophic lateral sclerosis. (AP Photo/Manuel Balce Ceneta)

FDA is told to tighten up its procedures for IT procurement

For the FDA, as for so many agencies, information technology is a big-ticket expenditure. The Health and Human Services inspector general examined FDA…

Management

HHS, Health and Human Services, building, exterior

HHS forms multidisciplinary team to enforce cybersecurity

Federal Drive

HHS OIG cyber team safeguards medical data

Cybersecurity

Potential for fraud CoE emerges amid agencies’ cyber risk responses

Technology